FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

EDELMAN RICHARD W 		2. Issuer Name and Ticker or Trading Symbol

MERIT MEDICAL SYSTEMS INC [ MMSI ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

1600 W. MERIT PARKWAY 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/24/2017
(Street)

SOUTH JORDAN, UT 84095
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value   5/24/2017   (1)   M    11621   (2) A $13.16   17621   D    
Common Stock, No Par Value   5/24/2017   (1)   S    7437   (2) D $34.50   10184   D    
Common Stock, No Par Value   5/25/2017   (1)   M    13379   (3) A $13.16   23563   D    
Common Stock, No Par Value   5/25/2017   (1)   S    8563   (3) D $34.420   (4) 15000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy)   $13.16   5/24/2017     M         11621    6/25/2011   (5) 6/25/2017   Common Stock   11621   $0   13379   D    
Non-qualified stock options (right to buy)   $13.16   5/25/2017     M         13379    6/25/2011   (5) 6/25/2017   Common Stock   13379   $0   0   D    
Non-qualified stock options (right to buy)   $13.75                    8/11/2012   (6) 8/11/2018   Common Stock   20000     20000   D    
Non-qualified stock options (right to buy)   $12.91                    5/23/2013   (7) 5/23/2019   Common Stock   20000     20000   D    
Non-qualified stock options (right to buy)   $9.95                    5/22/2014   (8) 5/22/2020   Common Stock   25000     25000   D    
Non-qualified stock options (right to buy)   $13.99                    6/11/2015   (9) 6/11/2021   Common Stock   25000     25000   D    
Non-qualified stock options (right to buy)   $20.27                    5/22/2016   (10) 5/22/2022   Common Stock   25000     25000   D    
Non-qualified stock options (right to buy)   $18.80                    5/26/2017   (11) 5/26/2023   Common Stock   25000     25000   D    

Explanation of Responses:
(1)  The Reporting Person ceased to be a director of the Issuer on March 24, 2017.
(2)  The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 7,437 of such shares to pay the exercise price and taxes and issuing the remaining 4,184 shares to the Reporting Person.
(3)  The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,563 of such shares to pay the exercise price and taxes and issuing the remaining 4,816 shares to the Reporting Person.
(4)  The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to 34.50, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(5)  Became exercisable in equal annual installments of 20% commencing 06/25/2011.
(6)  Became exercisable in equal annual installments of 20% commencing 08/11/2012.
(7)  Became exercisable in equal annual installments of 20% commencing 05/23/2013.
(8)  Became exercisable in equal annual installments of 20% commencing 05/22/2014. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
(9)  Became exercisable in equal annual installments of 20% commencing 06/11/2015. Installments scheduled for vesting after 6/11/2017 will not be exercisable.
(10)  Became exercisable in equal annual installments of 20% commencing 05/22/2016. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
(11)  Became exercisable in equal annual installments of 20% commencing 05/26/2017. Installments scheduled for vesting after 5/26/2017 will not be exercisable.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
EDELMAN RICHARD W
1600 W. MERIT PARKWAY
SOUTH JORDAN, UT 84095 		X



Signatures
Brian G. Lloyd, Attorney-in-Fact 5/26/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Merit Medical Systems Charts.
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Merit Medical Systems Charts.